Further research is warranted to elucidate the precise mechanisms involved and explore potential therapies targeting the NRG1/ErbB4 pathway, which could mitigate the adverse effects of prenatal morphine exposure and lead to novel therapeutic strategies for neurodevelopmental disorders. This evidence concerns the gene NRG1 and neurodevelopmental disorder.